SCHEMBL6963115

SCHEMBL6963115

Fc1ccc(C2CCCCN2c2ccc(F)cc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 1/20 0.48
TRPA1 O75762 3/20 0.46
ATM Q13315 1/20 0.43
MAPK1 P28482 1/20 0.43
TSHR P16473 1/20 0.43
LMNA P02545 1/20 0.43
PTBP1 P26599 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
HRH3 Q9Y5N1 1/20 0.41
KDM4E B2RXH2 1/20 0.40
GFER P55789 1/20 0.40
HSP90AA1 P07900 1/20 0.39
HTT P42858 1/20 0.39
PRKCZ Q05513 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4129691 0.89 NR3C2 (0.52) NR3C2TRPA1ATMMAPTHRH3
SCHEMBL28790764 0.87 ALDH1A1 (0.50) NR3C2TRPA1ATMMAPK1TSHR
SCHEMBL23623856 0.83 KDM4E (0.54) NR3C2TRPA1KDM4E
Hydrochloric Acid SCHEMBL6195686 0.81 CYP19A1 (0.43) MAPK1LMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL4608728 0.78 GAA (0.53) TSHRALDH1A1MAPTHRH3KDM4E
SCHEMBL1077622 0.78 CHRNB2 (0.52)
SCHEMBL15458234 0.77 NR3C2 (0.45) NR3C2TRPA1MAPK1TSHRLMNA
SCHEMBL2509355 0.76 TRPA1 (0.47) NR3C2TRPA1ATMMAPK1TSHR
SCHEMBL22473209 0.76 CHRNB2 (0.59)
SCHEMBL24060927 0.76 CHRNB2 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6620815-B1 Selective antagonists for human alpha 1A receptors; benign prostatic hyperplasia, impotency, cardiac arrhythmia treatment; anticholesterol agents; intraocular pressure reduction SYNAPTIC PHARMACEUTICAL CORPORATION 2003-09-16 US disclosed
EP-0988295-A4 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMA CORP (US) 2003-08-13 EP disclosed
US-6159990-A Oxazolidinones as α1A receptor antagonists SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-12-12 US disclosed
EP-0988295-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2000-03-29 EP disclosed
WO-1998057940-A1 HETEROCYCLIC SUBSTITUTED PIPERIDINES AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 1998-12-23 WO disclosed